Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Milica StoiljkovicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.
Katarina LalicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0002-8070-1899
Tanja MilicicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0001-7300-916X
Ljiljana LukicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0002-3513-4434
Marija MacesicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0001-9656-2523
Jelena Stanarcic GajovicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0009-0007-2969-1852
Mina MilovancevicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0002-0537-8139
Sara CvijanovicFaculty of Medicine, University of Belgrade, Doktora Subotica 8, 11000 Belgrade, Serbia.
Djurdja RafailovicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.
Stefan MaricClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.
Milica VujasevicFaculty of Medicine, University of Belgrade, Doktora Subotica 8, 11000 Belgrade, Serbia.
Nina Krako JakovljevicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0003-3908-5462
Kasja PavlovicClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.ORCID 0000-0003-0168-9631
Miroslava GojnicFaculty of Medicine, University of Belgrade, Doktora Subotica 8, 11000 Belgrade, Serbia.ORCID 0000-0002-7926-3916
Nebojsa LalicFaculty of Medicine, University of Belgrade, Doktora Subotica 8, 11000 Belgrade, Serbia.
Aleksandra JoticClinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Doktora Subotica 13, 11000 Belgrade, Serbia.
Funding
Ministry of Science, Technological Development and Innovation Republic of Serbia 451-03-66/2024-03/200110
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Gestational Diabetes Associated with Postpartum NAFLD Risk Meta-Analysis: Evidence for Sustained Metabolic Dysfunction Beyond Pregnancy. · full record | Socratic